Recently, a professional synthetic peptide manufacturing enterprise specializing in the peptide field in China officially released a complete business matrix to the public. The enterprise has integrated four core business segments: peptide pre research and development, personalized customized peptide synthesis, commercial large-scale peptide production, and full process supporting technical support, becoming one of the few local manufacturers to achieve independent operation of the entire peptide industry chain.

According to the technical director of the enterprise, the company has established an independent peptide research and development laboratory, which can undertake the research and development of cutting-edge molecules such as target peptides, modified cyclic peptides, and fluorescently labeled peptides; Customized synthesis business covers various long and short peptide needs of scientific research institutions and innovative pharmaceutical companies; Equipped with standardized GMP production workshops, it can achieve large-scale production from gram level to hundred kilogram level; Equipped with a dedicated team of technical engineers, we provide customers with one-stop support for process optimization, purity testing, and production technology guidance.

Industry insiders have stated that the current demand for GLP-1 peptide drugs, immune peptides, and diagnostic reagent peptides continues to surge. Peptide manufacturing companies with integrated research and development, customization, and mass production capabilities will effectively alleviate the problem of supply chain disruption in upstream and downstream, and help accelerate domestic biopharmaceutical research and development.